Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Benign gastric and duodenal ulceration Age: Adult Condition: Intermittent infusion |
Dose: Intravenous – 300 mg Frequency: every 6-8 hours Duration: infused over 15-20 minutes Note: Maximum: 2400 mg/day |
|
Indication: Benign gastric and duodenal ulceration Age: Adult Condition: Continuous infusion |
Dose: Intravenous – 37.5 mg/hour Note: 900 mg/day. A 150 mg intravenous loading dose may be given in patients requiring rapid elevation of gastric pH. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Duodenal ulcer, benign gastric ulcer, esophageal reflux disease Age: Children more than one year old |
Dose: Oral – 25-30 mg/kg body weight per day Frequency: Divided doses Note: Maximum dose 2.4 grams/day |
|
Indication: Duodenal ulcer, benign gastric ulcer, esophageal reflux disease Age: Infants under one year old |
Dose: Oral – 20 mg/kg body weight per day Frequency: Divided doses Note: Maximum dose 2.4 grams/day |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal Impairment with Creatinine Clearance less than 30 mL/minute |
Dose: Intravenous/Intraosseous – 300 mg Frequency: every 12 hours |
|
Indication: Prevention of upper gastrointestinal bleeding Condition: Renal Impairment with Creatinine Clearance less than 30 mL/minute |
Dose: Continuous intravenous infusion – 25 mg/hour Frequency: Continuous Note: Renal Impairment Creatinine Clearance less than 30 mL/minute |
Administration
- Take with food
- Follow regular schedule
Side Effect
- Headache (2.1%)
- Dizziness (1%)
- Somnolence (1%)
- Gynecomastia (0.3-4%)
- Confusion (elderly)
- Impotence
- Diarrhea
- Nausea
- Vomiting
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Dasatinib, Ketoconazole, Itraconazole, Posaconazole
|
Reduces absorption
|
|
Phenytoin, Theophylline, Lidocaine, Hydroxyzine, Oral Anticoagulants (Warfarin, Heparin, Dabigatran, Rivaroxaban, Apixaban, Edoxaban)
|
May increase serum levels
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for allergic reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.